Scott Bratman, MD, PhD

Dr. Scott Bratman is the Dr. Mariano Antonio Elia Chair in Head and Neck Cancer Research at University Health Network, Staff Radiation Oncologist at Princess Margaret Cancer Centre, and Associate Professor at University of Toronto. He serves as Research Director of Princess Margaret Cancer Centre's Radiation Medicine Program and Co-Chair of the Head and Neck Disease Site Committee at Canadian Cancer Trials Group (CCTG). Dr. Bratman is known for his contributions to novel liquid biopsy methods with immense scientific and clinical impact. His research has produced fundamental discoveries in cell-free DNA biology with implications for precision medicine and response monitoring in oncology. The Bratman Lab looks to accelerate discoveries in head and neck cancer biology, dynamic biomarkers, and risk-adapted therapy. Dr. Bratman holds a BA from Princeton University and an MD/PhD from Columbia University and conducted postdoctoral training at Stanford Cancer Institute.

Disclosures:

• Employment: University Health Network:Staff Radiation Oncologist - Clinician Scientist:Employee;Adela, Inc.:Co-Founder and CIO:Employee
• Compensation: EMD Serono: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: November 2023
• Ownership: Roche:Copyright;Adela, Inc.:Copyright, Stock
• Leadership: none